Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

TGFβ blockade enhances radiotherapy abscopal efficacy effects in combination with anti-PD1 and anti-CD137 immunostimulatory monoclonal antibodies.

Rodriguez-Ruiz ME, Rodriguez I, Mayorga L, Labiano T, Barbes B, Etxeberria I, Ponz-Sarvise M, Azpilikueta A, Bolaños E, Sanmamed MF, Berraondo P, Calvo FA, Barcellos-Hoff MH, Perez-Gracia JL, Melero I.

Mol Cancer Ther. 2019 Jan 25. pii: molcanther.0558.2018. doi: 10.1158/1535-7163.MCT-18-0558. [Epub ahead of print]

PMID:
30683810
2.

Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming.

Sánchez-Paulete AR, Teijeira Á, Quetglas JI, Rodríguez-Ruiz ME, Sánchez-Arráez Á, Labiano S, Etxeberria I, Azpilikueta A, Bolaños E, Ballesteros-Briones MC, Casares N, Quezada SA, Berraondo P, Sancho D, Smerdou C, Melero I.

Cancer Res. 2018 Dec 1;78(23):6643-6654. doi: 10.1158/0008-5472.CAN-18-0933. Epub 2018 Oct 8.

PMID:
30297531
3.

Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation.

Teijeira A, Labiano S, Garasa S, Etxeberria I, Santamaría E, Rouzaut A, Enamorado M, Azpilikueta A, Inoges S, Bolaños E, Aznar MA, Sánchez-Paulete AR, Sancho D, Melero I.

Cancer Immunol Res. 2018 Jul;6(7):798-811. doi: 10.1158/2326-6066.CIR-17-0767. Epub 2018 Apr 20.

PMID:
29678874
4.

Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB).

Azpilikueta A, Bolaños E, Lang V, Labiano S, Aznar MA, Etxeberria I, Teijeira A, Rodriguez-Ruiz ME, Perez-Gracia JL, Jure-Kunkel M, Zapata JM, Rodriguez MS, Melero I.

Oncoimmunology. 2017 Sep 21;7(1):e1368605. doi: 10.1080/2162402X.2017.1368605. eCollection 2017.

5.

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice.

González-López TJ, Alvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Pérez-Rus G, Hernández-Rivas JA, Bernat S, Bastida JM, Martínez-Badas MP, Martínez-Robles V, Soto I, Olivera P, Bolaños E, Alonso R, Entrena L, Gómez-Nuñez M, Alonso A, Yera Cobo M, Caparrós I, Tenorio M, Arrieta-Cerdán E, Lopez-Ansoar E, García-Frade J, González-Porras JR.

Br J Haematol. 2017 Sep;178(6):959-970. doi: 10.1111/bjh.14788. Epub 2017 Jun 1.

PMID:
28573819
6.

CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes.

Labiano S, Meléndez-Rodríguez F, Palazón A, Teijeira Á, Garasa S, Etxeberria I, Aznar MÁ, Sánchez-Paulete AR, Azpilikueta A, Bolaños E, Molina C, de la Fuente H, Maiso P, Sánchez-Madrid F, de Landázuri MO, Aragonés J, Melero I.

Oncoimmunology. 2017 Jan 19;6(4):e1283468. doi: 10.1080/2162402X.2017.1283468. eCollection 2017.

7.

Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming.

Rodriguez-Ruiz ME, Rodriguez I, Garasa S, Barbes B, Solorzano JL, Perez-Gracia JL, Labiano S, Sanmamed MF, Azpilikueta A, Bolaños E, Sanchez-Paulete AR, Aznar MA, Rouzaut A, Schalper KA, Jure-Kunkel M, Melero I.

Cancer Res. 2016 Oct 15;76(20):5994-6005. Epub 2016 Aug 22.

8.

First case with antithrombin deficiency, mesenteric vein thrombosis and pregnancy: Multidisciplinary diagnosis and successful management.

García-Botella A, Asenjo S, De la Morena-Barrio ME, Corral J, Bolaños E, Carlin PS, López ES, García AJ.

Thromb Res. 2016 Aug;144:72-5. doi: 10.1016/j.thromres.2016.05.011. Epub 2016 Jun 3. No abstract available.

PMID:
27304580
9.

Anti-CD137 monoclonal antibodies and adoptive T cell therapy: a perfect marriage?

Weigelin B, Bolaños E, Rodriguez-Ruiz ME, Martinez-Forero I, Friedl P, Melero I.

Cancer Immunol Immunother. 2016 May;65(5):493-7. doi: 10.1007/s00262-016-1818-5. Epub 2016 Mar 12.

PMID:
26970765
10.

Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism.

Labiano S, Palazón A, Bolaños E, Azpilikueta A, Sánchez-Paulete AR, Morales-Kastresana A, Quetglas JI, Perez-Gracia JL, Gúrpide A, Rodriguez-Ruiz M, Aznar MA, Jure-Kunkel M, Berraondo P, Melero I.

Oncoimmunology. 2015 Jun 24;5(1):e1062967. eCollection 2016.

11.

Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy.

Sanchez-Paulete AR, Labiano S, Rodriguez-Ruiz ME, Azpilikueta A, Etxeberria I, Bolaños E, Lang V, Rodriguez M, Aznar MA, Jure-Kunkel M, Melero I.

Eur J Immunol. 2016 Mar;46(3):513-22. doi: 10.1002/eji.201445388. Epub 2016 Feb 9. Review.

12.

Cost-benefit assessment of using electronic health records data for clinical research versus current practices: Contribution of the Electronic Health Records for Clinical Research (EHR4CR) European Project.

Beresniak A, Schmidt A, Proeve J, Bolanos E, Patel N, Ammour N, Sundgren M, Ericson M, Karakoyun T, Coorevits P, Kalra D, De Moor G, Dupont D.

Contemp Clin Trials. 2016 Jan;46:85-91. doi: 10.1016/j.cct.2015.11.011. Epub 2015 Nov 17.

PMID:
26600286
13.

Lengthening of the biliopancreatic limb is a key step during revisional Roux-en-Y gastric bypass for weight regain and diabetes recurrence.

Chaux F, Bolaños E, Varela JE.

Surg Obes Relat Dis. 2015 Nov-Dec;11(6):1411. doi: 10.1016/j.soard.2015.08.511. Epub 2015 Aug 29. No abstract available.

PMID:
26433642
14.

Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb.

Weigelin B, Bolaños E, Teijeira A, Martinez-Forero I, Labiano S, Azpilikueta A, Morales-Kastresana A, Quetglas JI, Wagena E, Sánchez-Paulete AR, Chen L, Friedl P, Melero I.

Proc Natl Acad Sci U S A. 2015 Jun 16;112(24):7551-6. doi: 10.1073/pnas.1506357112. Epub 2015 Jun 1.

15.

Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade.

Quetglas JI, Labiano S, Aznar MÁ, Bolaños E, Azpilikueta A, Rodriguez I, Casales E, Sánchez-Paulete AR, Segura V, Smerdou C, Melero I.

Cancer Immunol Res. 2015 May;3(5):449-54. doi: 10.1158/2326-6066.CIR-14-0216. Epub 2015 Feb 17.

16.

Cost-Benefit Assessment of the Electronic Health Records for Clinical Research (EHR4CR) European Project.

Beresniak A, Schmidt A, Proeve J, Bolanos E, Patel N, Ammour N, Sundgren M, Ericson M, De Moor G, Kalra D, Dupont D.

Value Health. 2014 Nov;17(7):A630. doi: 10.1016/j.jval.2014.08.2251. Epub 2014 Oct 26. No abstract available.

17.

Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.

Morales-Kastresana A, Sanmamed MF, Rodriguez I, Palazon A, Martinez-Forero I, Labiano S, Hervas-Stubbs S, Sangro B, Ochoa C, Rouzaut A, Azpilikueta A, Bolaños E, Jure-Kunkel M, Gütgemann I, Melero I.

Clin Cancer Res. 2013 Nov 15;19(22):6151-62. doi: 10.1158/1078-0432.CCR-13-1189. Epub 2013 Sep 12.

18.

Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb.

Morales-Kastresana A, Catalán E, Hervás-Stubbs S, Palazón A, Azpilikueta A, Bolaños E, Anel A, Pardo J, Melero I.

J Immunother Cancer. 2013 May 29;1:3. doi: 10.1186/2051-1426-1-3. eCollection 2013.

19.

Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytes.

Alfaro C, Suarez N, Oñate C, Perez-Gracia JL, Martinez-Forero I, Hervas-Stubbs S, Rodriguez I, Perez G, Bolaños E, Palazon A, Sanmamed MF, Morales-Kastresana A, Gonzalez A, Melero I.

PLoS One. 2011;6(12):e29300. doi: 10.1371/journal.pone.0029300. Epub 2011 Dec 20.

20.

Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer.

Argnani R, Marconi P, Volpi I, Bolanos E, Carro E, Ried C, Santamaria E, Pourchet A, Epstein AL, Brocker T, Corrales FJ, Manservigi R, Goicoechea I, Foschini M, Hernandez-Alcoceba R.

Liver Int. 2011 Nov;31(10):1542-53. doi: 10.1111/j.1478-3231.2011.02628.x. Epub 2011 Aug 25.

PMID:
22093330
21.

Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients.

Alfaro C, Perez-Gracia JL, Suarez N, Rodriguez J, Fernandez de Sanmamed M, Sangro B, Martin-Algarra S, Calvo A, Redrado M, Agliano A, Gonzalez A, Rodriguez I, Bolaños E, Hervás-Stubbs S, Perez-Calvo J, Benito A, Peñuelas I, Vigil C, Richter J, Martinez-Forero I, Melero I.

J Immunol. 2011 Dec 1;187(11):6130-42. doi: 10.4049/jimmunol.1102209. Epub 2011 Nov 2.

22.

Carcinoma-derived interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation.

Alfaro C, Suárez N, Martínez-Forero I, Palazón A, Rouzaut A, Solano S, Feijoo E, Gúrpide A, Bolaños E, Erro L, Dubrot J, Hervás-Stubbs S, Gonzalez A, Perez-Gracia JL, Melero I.

PLoS One. 2011 Mar 14;6(3):e17922. doi: 10.1371/journal.pone.0017922.

23.

Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo.

Suarez N, Alfaro C, Dubrot J, Palazon A, Bolaños E, Erro L, Hervas-Stubbs S, Martinez-Forero I, Morales-Kastresana A, Martin-Algarra S, Sangro B, Lecanda F, Perez-Gracia JL, Gonzalez A, Melero I.

Int J Cancer. 2011 Jul 15;129(2):374-86. doi: 10.1002/ijc.25681. Epub 2010 Nov 16.

24.

Risk factors for fatigue severity in primary brain tumor patients.

Armstrong TS, Cron SG, Bolanos EV, Gilbert MR, Kang DH.

Cancer. 2010 Jun 1;116(11):2707-15. doi: 10.1002/cncr.25018.

25.

Endoscopic treatment of gastrocutaneous fistula following gastric bypass for obesity.

Mejía AF, Bolaños E, Chaux CF, Unigarro I.

Obes Surg. 2007 Apr;17(4):544-6.

PMID:
17608269
26.

[Spanish physicians point of view on irritable bowel syndrome (IBS). Results of a Delphi survey].

Almansa C, Rey E, Bolaños E, Palma M, Alvarez Sánchez A, Díaz-Rubio M.

Rev Esp Enferm Dig. 2007 Apr;99(4):210-7. Spanish.

27.

Internet in clinical research based on a pilot experience.

López-Carrero C, Arriaza E, Bolaños E, Ciudad A, Municio M, Ramos J, Hesen W.

Contemp Clin Trials. 2005 Apr;26(2):234-43.

PMID:
15837443
28.
29.
30.

Publication bias in health economic studies.

Sacristán JA, Bolaños E, Hernández JM, Soto J, Galende I.

Pharmacoeconomics. 1997 Mar;11(3):289-92. No abstract available.

PMID:
10165318
31.

Bovine leukaemia-virus infection in Costa Rica.

Jiménez C, Bonilla JA, Dolz G, Rodriguez LR, Herrero L, Bolaños E, Cortéz MR, Moreno E.

Zentralbl Veterinarmed B. 1995 Sep;42(7):385-90.

PMID:
8594850
32.

Antiserum to the cell surface of oral epithelial cells: relationship to pemphigus antiserum.

Williams DR, Bolaños E, Dolby AE.

Br J Dermatol. 1978 Mar;98(3):339-42.

PMID:
638039
33.

[Doubts on the biological cycle of onchocerciasis].

BOLANOS EP.

Rev Col Med Guatem. 1962 Dec;13:220-2. Spanish. No abstract available.

PMID:
13968586

Supplemental Content

Loading ...
Support Center